InterventionsHuman trial
Petrelintide, a Human Amylin Analog for the Treatment of Obesity: Efficacy and Safety from the Phase 2 Trial, ZUPREME 1
ADA Scientific Sessions 2026 Abstract
The paper
GARVEY WT, CONNERY L, DINESEN M et al.
ADA Scientific Sessions 2026 Abstract · 5 Jun 2026
Presented at ADA Scientific Sessions 2026 · Late-breaking 3083-LB